| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.89B | 24.76B | 23.63B | 19.60B | 18.42B | 12.29B |
| Gross Profit | 3.74B | 3.55B | 3.72B | 3.40B | 2.71B | 2.09B |
| EBITDA | 1.73B | 1.64B | 1.96B | 1.53B | 1.51B | 1.04B |
| Net Income | 1.17B | 1.09B | 1.11B | 1.06B | 883.58M | 579.92M |
Balance Sheet | ||||||
| Total Assets | 30.62B | 29.38B | 27.59B | 22.21B | 19.02B | 16.07B |
| Cash, Cash Equivalents and Short-Term Investments | 8.22B | 8.62B | 7.03B | 5.26B | 3.23B | 2.65B |
| Total Debt | 3.14B | 3.16B | 2.78B | 2.15B | 1.95B | 1.13B |
| Total Liabilities | 17.35B | 16.28B | 15.21B | 12.69B | 10.52B | 8.60B |
| Stockholders Equity | 11.63B | 11.50B | 11.23B | 9.14B | 8.24B | 7.28B |
Cash Flow | ||||||
| Free Cash Flow | 903.53M | 1.41B | 933.14M | 2.11B | -251.32M | 591.03M |
| Operating Cash Flow | 1.92B | 2.49B | 1.78B | 2.56B | 434.65M | 960.08M |
| Investing Cash Flow | -1.26B | -1.90B | -2.08B | -483.95M | -557.61M | -480.84M |
| Financing Cash Flow | -203.04M | -375.43M | 1.98B | -77.08M | 753.69M | -406.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$3.27B | 5.50 | 8.78% | 3.59% | 10.16% | 49.48% | |
73 Outperform | HK$21.77B | 15.54 | 9.47% | 3.43% | 6.10% | 12.66% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | HK$70.14B | 7.80 | 8.45% | 3.59% | 2.58% | 7.10% | |
50 Neutral | HK$8.21B | -107.60 | -20.81% | ― | 17.21% | 59.09% | |
48 Neutral | HK$424.11M | -0.13 | -11.00% | ― | -2.11% | -779.00% | |
43 Neutral | HK$255.71M | -1.35 | -10.68% | ― | 0.97% | 33.70% |